Is a Single BRAF Wild-Type Test Sufficient to Exclude Melanoma Patients from Vemurafenib Therapy?

Subjects

Subjects :

Proto-Oncogene Proteins B-raf
Oncology
medicine.medical_specialty
Indoles
Skin Neoplasms
Dermatology
Biochemistry
Text mining
Internal medicine
medicine
Humans
Vemurafenib
Melanoma
Protein Kinase Inhibitors
Molecular Biology
Retrospective Studies
Sulfonamides
business.industry
Wild type
Cell Biology
medicine.disease
business
medicine.drug

Details

Language :

English

ISSN :

0022202X

Issue :

5

Database :

OpenAIRE

Journal :

Journal of Investigative Dermatology

Accession number :

edsair.doi.dedup.....9177d35c14f071c1baa4143b06ee3012

Full Text :

https://doi.org/10.1038/jid.2013.378